Search the Newsroom
Filter By
Showing 701 - 710 of 2709 results
On Second Anniversary of the Abraham Accords, CHOP Partners with International Collaborators to Focus on Advancing Medical Care and Education
Inaugural International Middle East Fetal-Neonatal Cardiovascular Symposium will be held in Abu Dhabi.
Children’s Hospital of Philadelphia and Main Line Health Announce New Affiliation
The new relationship brings CHOP’s world-class pediatric healthcare to patients and families across the award-winning Main Line Health System.
Meet One of Our Global Heath Fellows: Clarisse Casilang, MD
Clarisse Casilang, MD, is a board-certified general pediatrician and a fellow of the American Academy of Pediatrics.
CHOP Urologists Advocate Expanded Use of Nephron-Sparing Surgery for Wilms Tumor
Over the past decade, Children’s Hospital of Philadelphia (CHOP) Attending Pediatric Urologist Thomas Kolon, MD, has pioneered the use of nephron-sparing surgery — also known as partial nephrectomy — for Wilms tumor, the most common malignant renal tumor in childhood.
Diversity in Medicine: Dr. Srinivasan’s Story
Here, Arun K. Srinivasan, MD, MRCS, shares how his upbringing in India influenced his career path, and he discusses how racial disparities in medicine can be addressed.
CHOP Researchers Implicate Multiple Causal Genes that Drive Type 2 Diabetes Risk
CHOP researchers have used advanced 3D mapping techniques to identify genetic variants and corresponding target genes in the pancreas that are implicated in type 2 diabetes.
For Kids With Kidney Disease, Pediatric Expertise Is Key — But Not Always Close By
Dr. Sandra Amaral, attending physician in CHOP’s Division of Nephrology and the Kidney Transplant and Dialysis Program, led a study recently published in JAMA that found an association between dialysis facility ownership and access to the waiting list and transplant in pediatric patients with end-stage kidney disease in the United States. The findings were covered in this Kaiser Health News article.
Dr. Patrick Grohar Receives Stand Up to Cancer Catalyst Award
With support from Jazz Pharmaceuticals, the grant will fund a SU2C Catalyst® Research Team led by Dr. Grohar; the team will investigate new, targeted treatments for patients 10 years and older with Ewing sarcoma.
Researchers Map Genomic Landscape of ALL
A new study by a multi-institutional group of pediatric cancer researchers, including those at CHOP, has characterized the genomic landscape for acute lymphoblastic leukemia.
CHOP Researchers Discover First Therapeutic Option for Patients with Rare and Aggressive Form of Mitochondrial Disease
Variants of the FBXL4 gene cause a severe form of the disorder with many complications and no approved treatment options.